🇮🇱 Country Profile

Israel

Medicine from India reaching Israel

🇮🇱 $58.0M
All data from DGCIS India export records (fiscal year, April–March).
$58.0M
Scale
Israel's healthcare system receives $58.0M in Indian pharmaceutical products each year, affordable, quality medicine.
56%
Medicine
Primarily medicine ingredients (56%), supplemented by medicines and surgical & hospital supplies.
Context
Part of India's pharmaceutical supply network across Middle East.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Israel, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicine Ingredients $32.6M (55.8%) Medicines $16.4M (28.1%) Surgical & Hospital Supplies $5.8M (10.0%) Vaccines $2.6M (4.5%) Traditional & Herbal $0.97M (1.7%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in Israel Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Israel: $7.0M across 6 filings (2011-2018).